Safety, pharmacokinetics, and pharmacodynamics of Dapagliflozin (BMS-512148) in an ascending, placebo-controlled, multiple-dose study in healthy adult subjects

被引：0
|
作者：
Brenner, E. [1 ]
Komoroski, B. [1 ]
Boulton, D. [1 ]
Li, L. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0765
引用
收藏
页码：S316 / S316
页数：1
相关论文
共 50 条
  • [31] SINGLE- AND MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF THE DUAL ENDOTHELIN RECEPTOR ANTAGONIST APROCITENTAN IN HEALTHY ADULT AND ELDERLY SUBJECTS.
    Sidharta, P.
    Kankam, M.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S87 - S87
  • [32] Safety, tolerability and pharmacokinetics of HS-10383 in healthy subjects: A randomized, doubleblinded, placebo-controlled and multiple dose-ascending phase I trial
    Li, Qian
    Chen, Ke-Guang
    Zhang, Ye-Hui
    Zhou, Hai-Yan
    Ye, Pan-Pan
    Song, Lin-Lin
    Zhao, Fu-Rong
    Shi, Jin-Yi
    Wu, Qiong
    Zhang, Jing
    Jia, Wen
    Kong, Kai-Meng
    Tao, Yu-Ying
    Yang, Xin-Mei
    Zhao, Wei
    RESPIROLOGY, 2024, 29 : 196 - 196
  • [33] Multiple-dose pharmacokinetics and safety of amoxicillin/clavulanate in healthy elderly subjects
    Lee, Sang Won
    Choi, Yewon
    Jang, Kyungho
    Yoon, Seo Hyun
    Chung, Jae-Yong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (11) : 634 - 641
  • [34] Single-and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects
    Sidharta, Patricia N.
    Melchior, Meggane
    Kankam, Martin K.
    Dingemanse, Jasper
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 949 - 964
  • [35] Safety and Pharmacokinetics of Multiple-Dose BMS-986036 in Healthy Japanese and NonJapanese Adults
    Tirucherai, Giridhar
    Ide, Takafumi
    Shevell, Diane
    Mora, Johanna
    Charles, Edgar D.
    HEPATOLOGY, 2018, 68 : 756A - 757A
  • [36] Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Dingemanse, Jasper
    PHARMACOLOGY, 2018, 102 (5-6) : 339 - 346
  • [37] Safety and Pharmacokinetics of a Novel Formulation of Human Apolipoprotein A-I (CSL112) in Healthy Subjects: Results of a Placebo-Controlled, Randomized Multiple Ascending Dose Study
    Easton, Rachael
    Tremper, Louise
    Shear, Charles
    CIRCULATION, 2012, 126 (21)
  • [38] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE-DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS - A RANDOMIZED PLACEBO-CONTROLLED STUDY
    Zhao, Xia
    Payne, Christopher
    Wang, Feng
    Cui, Yiming
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 378 - 378
  • [39] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Zhao, Qian
    Liu, Hongzhong
    Wang, Zhenlei
    Wang, Teng
    Cui, Cheng
    Wang, Huanhuan
    Li, Lili
    Zhong, Wen
    Jiang, Ji
    Dong, Kai
    Chen, Shuai
    Jin, Chunyan
    Hu, Pei
    ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198
  • [40] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Qian Zhao
    Hongzhong Liu
    Zhenlei Wang
    Teng Wang
    Cheng Cui
    Huanhuan Wang
    Lili Li
    Wen Zhong
    Ji Jiang
    Kai Dong
    Shuai Chen
    Chunyan Jin
    Pei Hu
    Advances in Therapy, 2023, 40 : 3186 - 3198
12345